|
Lopinavir
|
DB01601 |
[Lopinavir is an antiretroviral belonging to the _protease inhibitor_ class. It is marketed by Abbott as Kaletra, a co-formulation with a sub-therapeutic dose of ritonavir, as a component of combination therapy to treat HIV/AIDS.] |
|
Pivampicillin
|
DB01604 |
[Pivalate ester analog of ampicillin.] |
|
(R)-Bicalutamide
|
DB02932 |
|
|
5'-Deoxy-5'-(Methylthio)-Tubercidin
|
DB02933 |
|
|
Meticillin
|
DB01603 |
[One of the penicillins which is resistant to penicillinase but susceptible to a penicillin-binding protein. It is inactivated by gastric acid so administered by injection.] |
|
Adenosine 5'-[γ-thio]triphosphate
|
DB02930 |
[A nucleoside triphosphate analogue that is ATP in which one of the oxygens attached to 3-phosphate group is replaced by sulfur.] |
|
CoA-s-acetyl tryptamine
|
DB02931 |
|
|
Tiaprofenic acid
|
DB01600 |
[Tiaprofenic acid is a non-steroidal anti-inflammatory drug employed in the treatment of pain, particularly arthritis pain. It belongs to the _arylpropionic acid_ (profen) group of nonsteroidal anti-inflammatory drugs (NSAIDs).] |
|
Imetelstat
|
DB14909 |
[Imetelstat is under investigation in clinical trial NCT01916187 (Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma).] |
|
Refanezumab
|
DB14908 |
[Refanezumab is under investigation in clinical trial NCT00833989 (Safety Escalating Repeat IV, in Stroke Patients).] |
|
Amylopectin
|
DB14927 |
[Amylopectin is under investigation in clinical trial NCT01708694 (Role of Slowly Digesible Starch on Diabetes Risk Factors).] |
|
Astuprotimut-R
|
DB14926 |
[Astuprotimut-R is under investigation in clinical trial NCT00257738 (0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck).] |
|
Elsulfavirine
|
DB14929 |
[Elsulfavirine is under investigation in clinical trial NCT03706898 (Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs).] |
|
Lacnotuzumab
|
DB14928 |
[Lacnotuzumab is under investigation in clinical trial NCT01643850 (MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)).] |
|
Satavaptan
|
DB14923 |
[Satavaptan is under investigation in clinical trial NCT00359437 (Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver).] |
|
Tislelizumab
|
DB14922 |
[Tislelizumab is under investigation in clinical trial NCT02660034 (The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Subjects With Advanced Solid Tumors).] |
|
Tenofovir exalidex
|
DB14925 |
[Tenofovir exalidex is under investigation in clinical trial NCT01080820 (A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers).] |
|
PF-06651600
|
DB14924 |
[PF-06651600 is under investigation in clinical trial NCT02974868 (Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata).] |
|
Mavacamten
|
DB14921 |
[Mavacamten is under investigation in clinical trial NCT03442764 (A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)).] |
|
Iboctadekin
|
DB14920 |
[Iboctadekin is under investigation in clinical trial NCT00500058 (A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18).] |
